Post-approval studies (Phase 4)Study completedNCT00686777
What this trial is testing
Pegylated Interferon (PEG-IFN) Alfa-2b and Low Dose Ribavirin for the Treatment of Chronic Hepatitis C Patients With Genotype 1 High Viral Load and Low Body Weight (Study P05172)(COMPLETED)
Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 75